A drug with the SMILES Cn1c(=O)c2cc(S(=O)(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)ccc2n(C)c1=O has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 20.976%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cn1c(=O)c2cc(S(=O)(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)ccc2n(C)c1=O
Cn1c(=O)c2cc(S(=O)(=O)Nc3cc(C(=O)O)cc(C(=O)O)c3)ccc2n(C)c1=O
5-[(1,3-dimethyl-2,4-dioxoquinazolin-6-yl)sulfonylamino]benzene-1,3-dicarboxylic acid